Autolus Therapeutics (AUTL) Other Gross PP&E Adjustments (2017 - 2025)

Autolus Therapeutics posted quarterly Other Gross PP&E Adjustments of -$40.1 million for Q4 2025, little changed year-on-year from -$40.0 million in Q4 2024, and up 3.43% on a QoQ basis from -$41.5 million in Q3 2025.

Autolus Therapeutics (AUTL) has 9 years of Other Gross PP&E Adjustments data on file, last reported at -$40.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments changed 0.13% year-over-year to -$40.1 million; the trailing twelve-month figure through Dec 2025 stood at -$40.1 million (changed 0.13% YoY), and the FY2025 full-year result was -$40.1 million, changed 0.13% from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 stood at -$40.1 million, up from -$41.5 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $10.5 million in Q4 2021 and bottomed at -$67.4 million in Q4 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$30.0 million (2023), against an average of -$28.5 million.
  • The widest annual swing landed in 2021, when Other Gross PP&E Adjustments jumped 119.62%; it then tumbled 2975.45% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $10.5 million in 2021, then plunged by 67.64% to $3.4 million in 2022, then sank by 2081.22% to -$67.4 million in 2023, then surged by 40.5% to -$40.1 million in 2024, then rose by 0.13% to -$40.1 million in 2025.
  • The last three Other Gross PP&E Adjustments figures came in at -$40.1 million (Q4 2025), -$41.5 million (Q3 2025), and -$56.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -83,048.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -60,691.22
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -892,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -1.69 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -189.30 Mn
10 Autolus Therapeutics - - -1.04 Mn -40.06 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -40.06 Mn
Dec 31, 2025 -40.06 Mn
Sep 30, 2025 -41.49 Mn
Sep 30, 2025 -41.49 Mn
Jun 30, 2025 -56.02 Mn
Jun 30, 2025 -56.02 Mn
Mar 31, 2025 -12.53 Mn
Mar 31, 2025 -12.53 Mn
Dec 31, 2024 -40.12 Mn
Dec 31, 2024 -40.12 Mn
Sep 30, 2024 -57.98 Mn
Sep 30, 2024 -57.98 Mn
Jun 30, 2024 -55.43 Mn
Jun 30, 2024 -55.43 Mn
Mar 31, 2024 -56.69 Mn
Mar 31, 2024 -56.69 Mn
Dec 31, 2023 -67.42 Mn
Dec 31, 2023 -67.42 Mn
Sep 30, 2023 -33.04 Mn
Sep 30, 2023 -33.04 Mn
Jun 30, 2023 -54.25 Mn
Jun 30, 2023 -54.25 Mn
Mar 31, 2023 -26.86 Mn
Mar 31, 2023 -26.86 Mn
Dec 31, 2022 3.40 Mn
Dec 31, 2022 3.40 Mn
Sep 30, 2022 -13.24 Mn
Sep 30, 2022 -13.24 Mn
Jun 30, 2022 -1.76 Mn
Jun 30, 2022 -1.76 Mn
Mar 31, 2022 -904,000.00
Mar 31, 2022 -904,000.00
Dec 31, 2021 10.52 Mn
Dec 31, 2021 10.52 Mn
Sep 30, 2021 -2.82 Mn
Sep 30, 2021 -2.82 Mn
Jun 30, 2021 -1.95 Mn
Jun 30, 2021 -1.95 Mn
Mar 31, 2021 -21.20 Mn
Mar 31, 2021 -21.20 Mn
Dec 31, 2020 -53.61 Mn
Dec 31, 2020 -53.61 Mn
Sep 30, 2020 -49.54 Mn
Sep 30, 2020 -49.54 Mn
Jun 30, 2020 -1.56 Mn
Jun 30, 2020 -1.56 Mn
Mar 31, 2020 -23.71 Mn
Mar 31, 2020 -23.71 Mn
Dec 31, 2019 -5.20 Mn
Dec 31, 2019 -5.20 Mn
Sep 30, 2019 -1.87 Mn
Sep 30, 2019 -1.87 Mn
Jun 30, 2019 -25.51 Mn
Jun 30, 2019 -25.51 Mn
Mar 31, 2019 -3.24 Mn
Mar 31, 2019 -3.24 Mn
Dec 31, 2018 -524,000.00
Dec 31, 2018 -524,000.00
Sep 30, 2018 10.47 Mn
Sep 30, 2018 10.47 Mn
Sep 30, 2017 2.10 Mn
Sep 30, 2017 2.10 Mn